Advisor Group Holdings, Inc. Axsome Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,215 shares of AXSM stock, worth $433,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,215
Previous 3,052
5.34%
Holding current value
$433,799
Previous $318,000
5.35%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding AXSM
# of Institutions
413Shares Held
37.4MCall Options Held
710KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$445 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$228 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$205 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$154 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.79B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...